Application of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug–Drug Interaction with Antidepressants

Tamoxifen is an estrogen receptor antagonist used in the treatment of breast cancer. It is a prodrug that is converted by several cytochrome P450 enzymes to a primary metabolite, N-desmethyltamoxifen (NDT), which is then further modified by CYP2D6 to a pharmacologically potent secondary metabolite,...

Descripción completa

Detalles Bibliográficos
Autores principales: MacLeod, A. Kenneth, McLaughlin, Lesley A., Henderson, Colin J., Wolf, C. Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193068/
https://www.ncbi.nlm.nih.gov/pubmed/27756789
http://dx.doi.org/10.1124/dmd.116.073437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193068/
https://www.ncbi.nlm.nih.gov/pubmed/27756789
http://dx.doi.org/10.1124/dmd.116.073437

Ejemplares similares